These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 15457355)
1. Factors predicting malignancy of Hürthle cell tumors of the thyroid: influence on surgical treatment. Pisanu A; Sias L; Uccheddu A World J Surg; 2004 Aug; 28(8):761-5. PubMed ID: 15457355 [TBL] [Abstract][Full Text] [Related]
2. [Predictive factors for malignancy in Hürthle-cell thyroid neoplasia. Effect of surgical treatment]. Pisanu A; Aste L; Piu S; Cois A; Uccheddu A Tumori; 2003; 89(4 Suppl):223-5. PubMed ID: 12903600 [TBL] [Abstract][Full Text] [Related]
3. The usefulness of 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. Boi F; Lai ML; Deias C; Piga M; Serra A; Uccheddu A; Faa G; Mariotti S Eur J Endocrinol; 2003 Dec; 149(6):493-8. PubMed ID: 14640989 [TBL] [Abstract][Full Text] [Related]
4. Hürthle cell tumor dwelling in hot thyroid nodules: preoperative detection with technetium-99m-MIBI dual-phase scintigraphy. Vattimo A; Bertelli P; Cintorino M; Burroni L; Volterrani D; Vella A; Lazzi S J Nucl Med; 1998 May; 39(5):822-5. PubMed ID: 9591583 [TBL] [Abstract][Full Text] [Related]
5. Oncocytic cell tumors of the thyroid: factors predicting malignancy and influencing prognosis, treatment decisions, and outcomes. Pisanu A; Di Chiara B; Reccia I; Uccheddu A World J Surg; 2010 Apr; 34(4):836-43. PubMed ID: 20041243 [TBL] [Abstract][Full Text] [Related]
6. Surgeon-performed ultrasound predictors of malignancy in patients with Hürthle cell neoplasms of the thyroid. Parikh PP; Allan BJ; Lew JI J Surg Res; 2013 Sep; 184(1):247-52. PubMed ID: 23535112 [TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of Hurthle cell tumors of the thyroid. Chao TC; Lin JD; Chen MF World J Surg; 2005 Feb; 29(2):164-8. PubMed ID: 15650796 [TBL] [Abstract][Full Text] [Related]
8. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553 [TBL] [Abstract][Full Text] [Related]
9. Intraoperative frozen-section analysis for thyroid nodules: a step toward clarity or confusion? Huber GF; Dziegielewski P; Matthews TW; Warshawski SJ; Kmet LM; Faris P; Khalil M; Dort JC Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):874-81. PubMed ID: 17875853 [TBL] [Abstract][Full Text] [Related]
10. Unilateral lobectomy for Hurthle cell adenoma. Wasvary H; Czako P; Poulik J; Lucas R Am Surg; 1998 Aug; 64(8):729-32; discussion 732-3. PubMed ID: 9697901 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of thyroid nodules--combined use of (99m)Tc-methylisobutylnitrile scintigraphy and aspiration cytology to assess risk of malignancy and stratify patients for surgical or nonsurgical therapy--a retrospective cohort study. Leidig-Bruckner G; Cichorowski G; Sattler P; Bruckner T; Sattler B Clin Endocrinol (Oxf); 2012 May; 76(5):749-58. PubMed ID: 22078001 [TBL] [Abstract][Full Text] [Related]
12. Demographic and histological subtypes of Hurthle cell tumours of the thyroid in a South African setting. Malith V; Bombil I; Harran N; Luvhengo TE S Afr J Surg; 2018 Sep; 56(3):20-23. PubMed ID: 30264938 [TBL] [Abstract][Full Text] [Related]
13. (99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology. Giovanella L; Suriano S; Maffioli M; Ceriani L; Spriano G Head Neck; 2010 May; 32(5):607-11. PubMed ID: 19693945 [TBL] [Abstract][Full Text] [Related]
14. Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid. Sippel RS; Elaraj DM; Khanafshar E; Zarnegar R; Kebebew E; Duh QY; Clark OH World J Surg; 2008 May; 32(5):702-7. PubMed ID: 18224463 [TBL] [Abstract][Full Text] [Related]
15. Thyroid Hürthle cell tumors: research of potential markers of malignancy. Donatini G; Beaulieu A; Castagnet M; Kraimps JL; Levillain P; Fromont G J Endocrinol Invest; 2016 Feb; 39(2):153-8. PubMed ID: 26188382 [TBL] [Abstract][Full Text] [Related]
16. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy? Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114 [TBL] [Abstract][Full Text] [Related]
17. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients. Rago T; Di Coscio G; Basolo F; Scutari M; Elisei R; Berti P; Miccoli P; Romani R; Faviana P; Pinchera A; Vitti P Clin Endocrinol (Oxf); 2007 Jan; 66(1):13-20. PubMed ID: 17201796 [TBL] [Abstract][Full Text] [Related]
18. Higher body mass index and larger waist circumference may be predictors of thyroid carcinoma in patients with Hürthle-cell lesion/neoplasm fine-needle aspiration diagnosis. Arduc A; Dogan BA; Tuna MM; Tutuncu Y; Isik S; Berker D; Guler S Clin Endocrinol (Oxf); 2015 Sep; 83(3):405-11. PubMed ID: 25296952 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of thyroid nodules for malignancy using 99Tcm-sestamibi. Sundram FX; Mack P Nucl Med Commun; 1995 Aug; 16(8):687-93. PubMed ID: 7491182 [TBL] [Abstract][Full Text] [Related]
20. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules. Batawil N; Alkordy T Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]